Bayer AG (BAY.WA)
BAY.WA Stock Price Chart
Explore Bayer AG interactive price chart. Choose custom timeframes to analyze BAY.WA price movements and trends.
BAY.WA Company Profile
Discover essential business fundamentals and corporate details for Bayer AG (BAY.WA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
27 Jun 2023
Employees
90.59K
Website
https://www.bayer.comCEO
William N. Anderson
Description
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases, as well as collaboration with Bicycle Therapeutics to develop bicyclic peptides. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
BAY.WA Financial Timeline
Browse a chronological timeline of Bayer AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 12 Nov 2025
Upcoming earnings on 6 Aug 2025
Revenue estimate is zł 10.79B.
Earnings released on 13 May 2025
EPS came in at zł 5.64 falling short of the estimated zł 9.71 by -41.92%, while revenue for the quarter reached zł 58.60B, beating expectations by +452.74%.
Dividend declared on 28 Apr 2025
A dividend of zł 0.47 per share was announced, adjusted to zł 0.47. The dividend was paid on 30 Apr 2025.
Earnings released on 5 Mar 2025
EPS came in at -zł 1.46 falling short of the estimated zł 4.24 by -134.39%, while revenue for the quarter reached zł 50.16B, beating expectations by +266.40%.
Earnings released on 12 Nov 2024
EPS came in at zł 1.03 falling short of the estimated zł 1.35 by -23.70%, while revenue for the quarter reached zł 199.30B, beating expectations by +352.81%.
Earnings released on 6 Aug 2024
EPS came in at -zł 0.15 falling short of the estimated zł 3.97 by -103.77%, while revenue for the quarter reached zł 48.16B, beating expectations by +1.55%.
Earnings released on 14 May 2024
EPS came in at zł 8.75 falling short of the estimated zł 9.97 by -12.24%, while revenue for the quarter reached zł 59.15B, missing expectations by -2.70%.
Dividend declared on 29 Apr 2024
A dividend of zł 0.48 per share was announced, adjusted to zł 0.48. The dividend was paid on 2 May 2024.
Earnings released on 5 Mar 2024
EPS came in at zł 5.96 falling short of the estimated zł 6.26 by -4.79%, while revenue for the quarter reached zł 51.98B, beating expectations by +2.05%.
Earnings released on 30 Sept 2023
EPS came in at -zł 21.51 falling short of the estimated zł 3.52 by -711.09%, while revenue for the quarter reached zł 47.83B, missing expectations by -2.69%.
Earnings released on 30 Jun 2023
EPS came in at -zł 8.54 falling short of the estimated zł 5.21 by -263.97%, while revenue for the quarter reached zł 49.12B, missing expectations by -6.77%.
Dividend declared on 2 May 2023
A dividend of zł 11.00 per share was announced, adjusted to zł 11.00. The dividend was paid on 4 May 2023.
Earnings released on 31 Mar 2023
EPS came in at zł 10.37 falling short of the estimated zł 12.83 by -19.17%, while revenue for the quarter reached zł 67.30B, missing expectations by -1.41%.
Earnings released on 31 Dec 2022
EPS came in at zł 2.90 falling short of the estimated zł 5.97 by -51.42%, while revenue for the quarter reached zł 56.01B, missing expectations by -0.45%.
Earnings released on 30 Sept 2022
EPS came in at zł 2.68 falling short of the estimated zł 5.49 by -51.18%, while revenue for the quarter reached zł 54.50B, beating expectations by +2.34%.
Earnings released on 30 Jun 2022
EPS came in at -zł 1.42 falling short of the estimated zł 8.95 by -115.91%, while revenue for the quarter reached zł 60.18B, beating expectations by +3.59%.
Dividend declared on 2 May 2022
A dividend of zł 9.40 per share was announced, adjusted to zł 9.40. The dividend was paid on 4 May 2022.
Earnings released on 31 Mar 2022
EPS came in at zł 15.54 surpassing the estimated zł 13.85 by +12.20%, while revenue for the quarter reached zł 67.92B, beating expectations by +5.62%.
Earnings released on 31 Dec 2021
EPS came in at zł 5.43, while revenue for the quarter reached zł 51.06B.
Earnings released on 30 Sept 2021
EPS came in at zł 0.40 falling short of the estimated zł 4.57 by -91.28%, while revenue for the quarter reached zł 45.08B, missing expectations by -7.25%.
Earnings released on 30 Jun 2021
EPS came in at -zł 10.73, while revenue for the quarter reached zł 48.98B.
Dividend declared on 28 Apr 2021
A dividend of zł 9.16 per share was announced, adjusted to zł 9.16. The dividend was paid on 30 Apr 2021.
Earnings released on 31 Mar 2021
EPS came in at zł 9.80, while revenue for the quarter reached zł 56.83B.
Earnings released on 31 Dec 2020
EPS came in at zł 1.43, while revenue for the quarter reached zł 45.62B.
Earnings released on 30 Sept 2020
EPS came in at -zł 12.57, while revenue for the quarter reached zł 38.29B.
BAY.WA Stock Performance
Access detailed BAY.WA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.